• 中国科技期刊卓越行动计划项目资助期刊
  • 中国精品科技期刊
  • EI
  • Scopus
  • CAB Abstracts
  • Global Health
  • 北大核心期刊
  • DOAJ
  • EBSCO
  • 中国核心学术期刊RCCSE A+
  • 中国科技核心期刊CSTPCD
  • JST China
  • FSTA
  • 中国农林核心期刊
  • 中国开放获取期刊数据库COAJ
  • CA
  • WJCI
  • 食品科学与工程领域高质量科技期刊分级目录第一方阵T1
中国精品科技期刊2020
刘方祥,王风青,郑佳,等. 一株贝莱斯芽孢杆菌SL的体外益生特性J. 食品工业科技,2026,47(4):1−11. doi: 10.13386/j.issn1002-0306.2025010145.
引用本文: 刘方祥,王风青,郑佳,等. 一株贝莱斯芽孢杆菌SL的体外益生特性J. 食品工业科技,2026,47(4):1−11. doi: 10.13386/j.issn1002-0306.2025010145.
LIU Fangxiang, WANG Fengqing, ZHENG Jia, et al. Evaluation of Probiotic Properties of Bacillus velezensis SL In VitroJ. Science and Technology of Food Industry, 2026, 47(4): 1−11. (in Chinese with English abstract). doi: 10.13386/j.issn1002-0306.2025010145.
Citation: LIU Fangxiang, WANG Fengqing, ZHENG Jia, et al. Evaluation of Probiotic Properties of Bacillus velezensis SL In VitroJ. Science and Technology of Food Industry, 2026, 47(4): 1−11. (in Chinese with English abstract). doi: 10.13386/j.issn1002-0306.2025010145.

一株贝莱斯芽孢杆菌SL的体外益生特性

Evaluation of Probiotic Properties of Bacillus velezensis SL In Vitro

  • 摘要: 本文以一株贝莱斯芽孢杆菌SL(Bacillus velezensis SL)为研究对象,系统评估了其体外益生特性,旨在为微生态制剂的开发提供理论依据。通过模拟胃肠道耐受性实验、抗生素敏感性测试、细胞表面特性分析、抗氧化活性测定、抑菌能力测试及代谢组学分析,系统评估了菌株SL的益生特性。结果表明:菌株SL在模拟肠液中存活率>80%,但胃酸耐受性较差(120 min存活率4.11%),对高浓度胆盐(0.6%)耐受性良好;菌株SL对7种抗生素敏感,不具备耐药基因;该菌疏水能力为19.08%,12 h自聚集率达86%,具备较强肠道定植潜力;抗氧化实验中,菌株SL对羟基自由基(·OH)和超氧阴离子(O2·)的清除率分别为23.84%和34.18%,对DPPH和ABTS+自由基的清除率分别为37.40%和36.52%,表明其具有中等的自由基清除能力;菌株SL对沙门氏菌、产气荚膜梭菌、金黄色葡萄球菌等病原菌表现一定抑菌作用,对革兰氏阳性菌的抑制作用更佳;代谢组学分析表明,菌株SL代谢产生的挥发性化合物(如异丁酸、2-甲基丁酸)可促进消化酶活性和肠道发育,而非挥发性代谢物(如9-硝基油酸、丹叶大黄素、棕榈酰甘氨酸等)具有抗炎、抗菌和抗氧化功能。这些结果证明,菌株SL具有开发为微生态制剂的潜力,但需通过包埋或菌种改良提升胃酸稳定性以优化应用性能。

     

    Abstract: In this study, we systematically evaluated the in vitro characteristics of Bacillus velezensis SL to assess its potential as a probiotic. The probiotic properties of strain SL were systematically evaluated using a simulated gastrointestinal tolerance test, antibiotic sensitivity test, cell surface characteristic analysis, antioxidant activity determination, bacteriostatic ability test, and metabolomics technology. The results showed that the survival rate of strain SL in the simulated intestinal fluid was>80%. However, gastric acid tolerance was poor (120 min survival rate was 4.11%), and tolerance to high concentrations of bile salt (0.6%) was good. In addition, strain SL was sensitive to seven antibiotics and did not harbor any resistance genes. The hydrophobicity of the bacteria was 19.08%, and the self-aggregation rate at 12 h was 86%, indicating strong intestinal colonization potential. In the antioxidant experiment, the scavenging rates of strain SL on hydroxyl radicals (·OH) and superoxide anions (O2·) were 23.84% and 34.18%, respectively, and the scavenging rates of 2,2-diphenyl-1-picrylhydrazyl (DPPH) and 2,2’-azino-bis(3-ethylbenzothiazoline-6-sulfonic acid) (ABTS+) radical were 37.40% and 36.52%, respectively, indicating moderate free radical scavenging abilities. Strain SL showed a certain bacteriostatic effect on pathogenic bacteria such as Salmonella, Clostridium perfringens, and Staphylococcus aureus, and exhibited a good inhibitory effect on Gram-positive bacteria. Metabolomic analysis identified both volatile (such as isobutyric acid and 2-methylbutyric acid) and nonvolatile (such as 9-nitrooleic acid, danye-emodin, and palmitoylglycine) metabolites with potential benefits for digestive enzyme activity and intestinal development, as well as anti-inflammatory, antimicrobial, and antioxidant properties. These results indicate that strain SL has the potential to be developed as a microecological agent. However, the stability of gastric acid should be enhanced by embedding or strain improvement to optimize its application performance.

     

/

返回文章
返回